Literature DB >> 6258582

Purification and partial characterization of high-molecular-weight forms of ectopic calcitonin from a human bronchial carcinoma cell line.

J Lumsden, J Ham, M L Ellison.   

Abstract

Studies on the high-molecular-weight immunoreactive calcitonin produced ectopically in culture by an epidermoid bronchial carcinoma cell line are reported. In cell-exposed medium, the principal component has a molecular weight of 40000 and molecules of mol.wts. 13000 and 10000 also occur. Only a trace amount of material co-eluting with 35000-mol.wt. human calcitonin is detectable. None of the calcitonins show cross-reactivity with anti-corticotropin serum. The 40000-mol.wt. immunoreactive calcitonin is readily proteolysed to the 13000- and 10000-mol.wt. components, but the 10000-mol.wt. component behaves as a comparatively stable 'core' molecule. By using immunoprecipitation and high-pressure liquid chromatography (h.p.l.c.), it is possible to prepare radiochemically homogeneous 10000-mol.wt. immunoreactive calcitonin from cells grown in the presence of individual 35S- or 3H-labelled amino acids. Peptide mapping of enzymic digests of this material by h.p.l.c. shows that it contains peptides in common with synthetic human calcitonin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6258582      PMCID: PMC1162203          DOI: 10.1042/bj1910239

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Evidence for a pro-calcitonin.

Authors:  B A Roos; K Okano; L J Deftos
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

2.  Ectopic secretion of calcitonin by oat-cell carcinoma.

Authors:  O L Silva; K L Becker; A Primack; J Doppman; R H Snider
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

3.  Production of a corticotrophin-like intermediate lobe peptide and of corticotrophin by a bronchial carcinoid tumour.

Authors:  J G Ratcliffe; A P Scott; H P Bennett; P J Lowry; C McMartin; J A Strong; P R Walbaum
Journal:  Clin Endocrinol (Oxf)       Date:  1973-01       Impact factor: 3.478

4.  A radioimmunoassay for rat plasma ACTH.

Authors:  L H Rees; D M Cook; J W Kendall; C F Allen; R M Kramer; J G Ratcliffe; R A Knight
Journal:  Endocrinology       Date:  1971-07       Impact factor: 4.736

5.  Letter: Hypersecretion of calcitonin in neoplastic conditions.

Authors:  G Milhaud; C Calmette; J Taboulet; A Julienne; M S Moukhtar
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

6.  Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours.

Authors:  R C Coombes; C Hillyard; P B Greenberg; I MacIntyre
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

7.  Multiple immunoreactive forms of calcitonin in human plasma.

Authors:  F R Singer; J F Habener
Journal:  Biochem Biophys Res Commun       Date:  1974-11-27       Impact factor: 3.575

8.  Immunochemical studies on human calcitonin M leading to information on the shape of the molecule.

Authors:  P G Byfield; M B Clark; K Turner; G V Foster; I MacIntyre
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

9.  Antigenic site(s) of synthetic human calcitonin M.

Authors:  F M Dietrich; W Rittel
Journal:  Nature       Date:  1970-01-03       Impact factor: 49.962

10.  [Human calcitonin. Structure of calcitonin M and D].

Authors:  R Neher; B Riniker; W Rittel; H Zuber
Journal:  Helv Chim Acta       Date:  1968       Impact factor: 2.164

View more
  5 in total

1.  The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein.

Authors:  J Allison; L Hall; I MacIntyre; R K Craig
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

2.  Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.

Authors:  J M Conlon; L Grimelius; L Thim
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

3.  Ectopically produced calcitonin in human hemoblastoses.

Authors:  K H Pflüger; C Gropp; K Havemann
Journal:  Klin Wochenschr       Date:  1982-07-01

4.  Plasma calcitonin in small cell lung cancer: prognostic significance.

Authors:  A P Sappino; S Carter; M Ellison; I E Smith
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

5.  Monoclonal antibodies against two human lung carcinoma cell lines.

Authors:  D T Brown; M Moore
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.